A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance

Copyright © 2012 John Wiley & Sons, Ltd.

Détails bibliographiques
Publié dans:Magnetic resonance in chemistry : MRC. - 1985. - 51(2013), 2 vom: 01. Feb., Seite 102-9
Auteur principal: Mehrpour, Masoud (Auteur)
Autres auteurs: Kyani, Anahita, Tafazzoli, Mohsen, Fathi, Fariba, Joghataie, Mohammad-Taghi
Format: Article en ligne
Langue:English
Publié: 2013
Accès à la collection:Magnetic resonance in chemistry : MRC
Sujets:Journal Article Selenium H6241UJ22B
Description
Résumé:Copyright © 2012 John Wiley & Sons, Ltd.
Multiple sclerosis (MS) is a nervous system disease that affects the fatty myelin sheaths around the axons of the brain and spinal cord, leading to demyelination and a broad range of signs and symptoms. MS can be difficult to diagnose because its signs and symptoms may be similar to other medical problems. To find out which metabolites in serum are effective for the diagnosis of MS, we utilized metabolic profiling using proton nuclear magnetic resonance spectroscopy ((1)H-NMR). Random forest (RF) was used to classify the MS patients and healthy subjects. Atomic absorption spectroscopy was used to measure the serum levels of selenium. The results showed that the levels of selenium were lower in the MS group, when compared with the control group. RF was used to identify the metabolites that caused selenium changes in people with MS by building a correlation model between these metabolites and serum levels of selenium. For the external test set, the obtained classification model showed a 93% correct classification of MS and healthy subjects. The regression model of levels of selenium and metabolites showed the correlation (R(2)) value of 0.88 for the external test set. The results indicate the suitability of NMR as a screen for identifying MS patients and healthy subjects. A novel model with good prediction outcomes was constructed between serum levels of selenium and NMR data
Description:Date Completed 09.07.2013
Date Revised 21.11.2013
published: Print-Electronic
Citation Status MEDLINE
ISSN:1097-458X
DOI:10.1002/mrc.3915